Nebulised interferon as a COVID-19 medicine
In a small clinical study conducted in April and May 2020, British scientists investigated the effect of inhalation of nebulised interferon-beta-1a (SNG001) on the development of COVID-19 in patients. The results are encouraging and justify further research. Lung infections Being … Read more